<DOC>
	<DOCNO>NCT02092389</DOCNO>
	<brief_summary>The objective study explore fecal calprotectin ( fC ) level UC patient adalimumab therapy correlation general wellbeing ( Quality Life [ QoL ] ) , workability , disease activity .</brief_summary>
	<brief_title>Fecal Calprotectin Levels , Quality Life , Workability Patients Suffering From Ulcerative Colitis Under Adalimumab Therapy - AdaProQuo</brief_title>
	<detailed_description>This non-interventional , observational study Humira ( adalimumab ) prescribe usual manner accordance term local marketing authorization regard dose , population indication . The assignment patient adalimumab contain regimen decide advance current practice . The prescription adalimumab clearly separate decision include participant study .</detailed_description>
	<mesh_term>Ulcer</mesh_term>
	<mesh_term>Colitis , Ulcerative</mesh_term>
	<mesh_term>Colitis</mesh_term>
	<mesh_term>Adalimumab</mesh_term>
	<criteria>Patients moderate severe ulcerative colitis ( UC ) respond despite full adequate course therapy corticosteroid immunosuppressant ( AZA/6MP ) ; intolerant medical contraindication therapy hence prescribe adalimumab treatment moderate severely active UC Patients able complete patient questionnaire ( e.g. , WPAI : UC sIBDQ questionnaire ) Patients must fulfill national international guideline use biologic therapy UC ( Chest Xray InterferonGammaRelease Assay ( IGRA ) tuberculin purify protein derivative ( PPD ) skin test negative tuberculosis ) . Patients prescribed adalimumab line European SmPC ( Summary Product Characteristics ) Previous therapy TNFalpha ( Tumor necrosis factor alpha ) blocker No sign write authorization use data Contraindication adalimumab therapy accord SmPC Patients history subtotal colectomy ileorectostomy colectomy ileoanal pouch , Koch pouch , ileostomy UC plan bowel surgery . Patients receive intravenous ( IV ) corticosteroid within 14 day Screening Screening period . Pregnant patient</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Ulcerative Colitis</keyword>
	<keyword>Inflammatory Bowel Syndrome</keyword>
	<keyword>Adalimumab</keyword>
	<keyword>Tumor necrosis factor ( TNF ) alpha Antibody</keyword>
	<keyword>Calprotectin</keyword>
</DOC>